Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00000413 · ClinicalTrials.gov registry record · Phase 2

Osteoporosis Prevention in Preadolescent Girls

A Phase 2 study of Osteoporosis, sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).

Completed
Registry status
Phase 2
Development phase
340
Enrollment target
1
Study location

NCT00000413: Completed Phase 2 study of Osteoporosis, sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).

NCT00000413 is a Phase 2 study of Osteoporosis that has completed, run by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The registered enrollment target is 340 participants, below the 1,542-participant average among 84 other Osteoporosis trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00000413, a Phase 2 study of Osteoporosis, has completed, sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).

COMPLETED
Registry status
Phase 2
Development phase
340 participants
Enrollment target
1
Study location

Study Summary

This study will test an osteoporosis prevention program aimed at preadolescent girls between the ages of 10 and 12 who have not yet started their menstrual periods. Girls in this age group are adding large amounts of new bone to their skeletons. Adding more bone at this time of life can reduce a person's chances of developing osteoporosis (thinning bones) in later years. We will look at how this osteoporosis prevention program affects the amount of calcium in the girls' diets, the amount of weight-bearing exercise they do, and their bone mass measured using ultrasound testing of the heel.

Conditions Studied

Interventions

  • BEHAVIORAL Psychoeducational program

Study Locations (1)

Ohio

  • University Hospitals of Cleveland - Cleveland

Trial Details

FieldValue
Enrollment Target 340 participants
Start Date 1998-07
Est. Completion 2002-06
Phase Phase 2

What the finished NCT00000413 record still lists

NCT00000413 is an interventional study that assigns participants to a tested intervention. The registered 340 participants enrollment target is mid-sized for trials with a published cap, below the 1,542-participant average among 84 other Osteoporosis trials with a reported enrollment target (78% lower).

The record links to 1 condition, with Osteoporosis appearing as the primary indexed condition, and to 1 intervention - of which Psychoeducational program is the first listed.

NCT00000413 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT00000413 about?

NCT00000413 is a clinical study titled "Osteoporosis Prevention in Preadolescent Girls". This study will test an osteoporosis prevention program aimed at preadolescent girls between the ages of 10 and 12 who have not yet started their menstrual periods. Girls in this age group are adding large amounts of new bone to their skeletons. Adding more bone at this time of life can reduce a per...

What is the current status of trial NCT00000413?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 340 participants. The study started on 1998-07. Estimated completion is 2002-06.

What conditions does trial NCT00000413 study?

This clinical trial studies the following conditions: Osteoporosis.

What interventions are being tested in trial NCT00000413?

The interventions under investigation include: Psychoeducational program (BEHAVIORAL).

Who is sponsoring clinical trial NCT00000413?

This trial is sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), which has 93 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00000413 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoporosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00000413's enrollment target sits among peer trials

340 26th of 84 higher than 59 of 84 other Osteoporosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Osteoporosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04176172 · 340 participants · Phase 3

    Optimizing Tobacco Use Treatment for PLWHA

  • NCT04545424 · 340 participants · Phase 2

    Trial of Therapeutic Hypothermia in Patients With ARDS

  • NCT04806958 · 340 participants · NA

    The PulsePoint Study

  • NCT05323409 · 340 participants · NA

    Improving Comprehensive Care of Cancer Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00000413, the US trial registry maintained by the National Library of Medicine. NCT00000413 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.